Found: 20
Select item for more details and to access through your institution.
Adherence, Persistence, Switching and Costs of Injectable and Oral Therapies for Multiple Sclerosis. Real Life Analysis Over 6 Years of Treatment.
- Published in:
- Hospital Pharmacy, 2024, v. 59, n. 4, p. 476, doi. 10.1177/00185787241232615
- By:
- Publication type:
- Article
The lack of head-to-head randomised trials and the consequences for patients and national health service: The case of non-small cell lung cancer.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 4, p. 519, doi. 10.1007/s00228-024-03628-2
- By:
- Publication type:
- Article
Antidepressant deprescribing: State of the art and recommendations—A literature overview.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 3, p. 417, doi. 10.1007/s00228-023-03617-x
- By:
- Publication type:
- Article
A multicentre study with real-world data of the use of palbociclib in the treatment of breast cancer: Treatment duration correlates with dose reductions.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1806, doi. 10.1177/10781552221117135
- By:
- Publication type:
- Article
Healthcare Resource Consumption and Related Costs in Patients on Antiretroviral Therapies: Findings from Real-World Data in Italy.
- Published in:
- International Journal of Environmental Research & Public Health, 2023, v. 20, n. 5, p. 3789, doi. 10.3390/ijerph20053789
- By:
- Publication type:
- Article
Healthcare Systems across Europe and the US: The Managed Entry Agreements Experience.
- Published in:
- Healthcare (2227-9032), 2023, v. 11, n. 3, p. 447, doi. 10.3390/healthcare11030447
- By:
- Publication type:
- Article
Available information about paediatric use of onco-haematological drugs authorized by EMA since 2016.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 83, doi. 10.1177/10781552211053251
- By:
- Publication type:
- Article
Adherence, Persistence, and Effectiveness in Real Life. Multicenter Long-Term Study on the Use of Pirfenidone and Nintedanib in the Treatment of Idiopathic Pulmonary Fibrosis.
- Published in:
- Journal of Pharmacy Practice, 2022, v. 35, n. 6, p. 853, doi. 10.1177/08971900211008625
- By:
- Publication type:
- Article
Randomized clinical trials and real life studies: Comparison of baseline characteristics of patients in oral target therapies for renal cell carcinoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 870, doi. 10.1177/10781552211005518
- By:
- Publication type:
- Article
Association between adherence to oral therapies in cancer patients and clinical outcome: A systematic review of the literature.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 5, p. 1999, doi. 10.1111/bcp.15147
- By:
- Publication type:
- Article
Adherence to and effectiveness of lenalidomide after 1 year of treatment in a real world setting.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 24, doi. 10.1177/1078155220980807
- By:
- Publication type:
- Article
Real-life adherence in capecitabine therapy using two analysis methods and persistence after 6 months of treatment.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 5, p. 1112, doi. 10.1177/1078155220949634
- By:
- Publication type:
- Article
Drug utilisation pattern over 3 years in the real-world treatment of type II diabetes.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Drug utilisation pattern over 3 years in the real‐world treatment of type II diabetes.
- Published in:
- International Journal of Clinical Practice, 2021, v. 75, n. 6, p. 1, doi. 10.1111/ijcp.14120
- By:
- Publication type:
- Article
Cancer drugs for solid tumors approved by the EMA since 2014: an overview of pivotal clinical trials.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 6, p. 843, doi. 10.1007/s00228-020-02850-y
- By:
- Publication type:
- Article
Using a treatment diary to improve the medication adherence in patients with chronic myeloid leukaemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 5, p. 1035, doi. 10.1177/1078155218759184
- By:
- Publication type:
- Article
Dosage adjustments in pivotal clinical trials with oral targeted therapies in solid tumors conducted in Europe.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 5, p. 697, doi. 10.1007/s00228-018-02621-w
- By:
- Publication type:
- Article
Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district.
- Published in:
- ClinicoEconomics & Outcomes Research, 2016, v. 8, p. 467, doi. 10.2147/CEOR.S106238
- By:
- Publication type:
- Article
Medication Adherence to Tyrosine Kinase Inhibitors: 2-Year Analysis of Medication Adherence to Imatinib Treatment for Chronic Myeloid Leukemia and Correlation with the Depth of Molecular Response.
- Published in:
- Acta Haematologica, 2016, v. 136, n. 1, p. 45, doi. 10.1159/000444626
- By:
- Publication type:
- Article
Patient Adherence and Persistence with Imatinib, Nilotinib, Dasatinib in Clinical Practice.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0056813
- By:
- Publication type:
- Article